Healthcare >> CEO Interviews >> September 13, 2002

Thomas D’ambra – Albany Molecular Research Inc (amri)

THOMAS E. D'AMBRA, PhD is Founder, Chairman of the Board of Directors and Chief Executive Officer of Albany Molecular Research, Inc. Dr. D'Ambra began his career in the Medicinal Chemistry Department at Sterling Winthrop Pharmaceuticals as a senior research chemist. He was later promoted to Group Leader and co-Project Leader. During his seven- year tenure at Sterling Winthrop, Dr. D'Ambra participated in drug research programs in the endocrine, cardiovascular and analgesic therapeutic areas. In 1989, Dr. D'Ambra co-founded Coromed, Inc., a clinical research organization where he established the chemistry and biology departments and served as Vice President, Chemistry. In 1991, Dr. D'Ambra left Coromed and founded Albany Molecular Research. At AMRI, he has been involved in many different aspects of the growing business, from bench research scientist to business development to management. Dr. D'Ambra received a Bachelor's degree in Chemistry from the College of the Holy Cross and a doctorate in Organic Chemistry from the Massachusetts Institute of Technology. He has authored numerous publications and is inventor on over 30 patents. Profile
TWST: Would you begin with a brief description of Albany Molecular


Mr. D'Ambra: Albany Molecular Research is a healthcare R&D company built

upon a chemistry platform of